|Issuer:||BIOHAVEN PHARMACEUTICAL HOLDING CO LTD. (BHVN)|
|Original Submission Date:|
C/O BIOHAVEN PHARMACEUTICALS, INC.
215 CHURCH STREET NEW HAVEN, CT 06510
|Title of Security||Transaction Date||2a. Deemed Execution Date||Transaction Code||Shares||Acquired or Disposed||Price per share||5. Amount of Securities Beneficially Owned Following Reported Transaction||6. Ownership Form Direct or Indirect||Nature of Indirect Ownership|
|Title of Derivative Security||Conversion or Exercise Price of Derivative Security||Transaction Date||Deemed Execution Date||Transaction Code||Number of Derivative Securities Acquired (A) or Disposed of (D)||Date Exercisable||Expiration Date||Title and Amount of Securities Underlying Derivative Security||Price of Derivative Security||Number of derivative Securities Beneficially Owned Following Reported Transaction(s)||Ownership Form: Direct (D) or Indirect (I)||Nature of Indirect Beneficial Ownership|
|f1||the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices from $72.05 - $72.22, inclusive. the reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this form 4.|
|f2||this balance includes 731 shares that were acquired through the company employee share purchase plan on november 30, 2020.|